Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Nova Paid Stream

 

Interview: Michael Sandhu, Remedium RT

After a long career at radiotherapy supplier Varian where he ended as Vice President, Global Market Development, Michael has set up his own consultancy to advise governments, international agencies and the private sector on the development of radiation therapy services in general and the best business models.  HBI asks him where the opportunities are and what they look like. 

HBI Deals + Insights Briefing December 2018/January 2019

Click here to see your HBI Deals + Insights Briefing for December 2018/January 2019 In this first edition of HBI Deals + Insights, we analyse the listed hospital sector in developed markets complete with infographics. We also look at the sale of Belgian nursing home operator Armonea, whether Dutch hospital bankruptcies could herald the death […]

HBI Deals + Insights Briefing December 2018/January 2019

Click here to see your HBI Deals + Insights Briefing for December 2018/January 2019 In this first edition of HBI Deals + Insights, we analyse the listed hospital sector in developed markets complete with infographics. We also look at the sale of Belgian nursing home operator Armonea, whether Dutch hospital bankruptcies could herald the death […]

Saudi dialysis grows double-digits in 2017

The number of dialysis patients treated by Diaverum and DaVita in Saudi Arabia nearly doubled in 2017, while the overall dialysis population grew double-digits and will do so again in 2018, according to an official report. Based on session payment rates reported by HBI, the 2017 market was worth around US$800m.

TVM Capital is divesting, and investing

HBI hears that investment group TVM Capital will soon be looking to divest itself of its healthcare services assets, and is looking at fresh investments in the sector.

Notre Dame Intermedica looking to raise $775m with new share issue

Grupo Notre Dame Intermedica (GNDI), one of Brazil's largest hospital groups, is hoping to raise around R$3bn ($775m) from the sale of new shares this month. We speak to a Brazilian healthcare expert to find out what this means for the company and investors.

Diaverum grows in Brazil through acquisitions

International dialysis provider Diaverum has expanded in Brazil with the acquisition of three clinics following its initial entry into Latin America's largest market in January, 2018.

Find Us